<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Sinusitis MeG-CLS-062</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="sinusitis">Sinusitis</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Sinusitis is an acute inflammatory condition of one or more of the paranasal sinuses. Infection plays an important role in this affliction. Sinusitis often results from infections of other sites of the respiratory tract since the paranasal sinuses are contiguous to, and communicate with, the upper respiratory tract. Acute sinusitis is commonly viral but a bacterial cause is likely if it persists for 7-10 days or worsens within 10 days after initial relief.</p>
<p><em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em>, and <em>Moraxella catarrhalis</em> are the commonest bacterial aetiology for acute sinusitis. Chronic sinusitis is commonly a mixed infection of aerobic and anaerobic organisms.</p>
<p>Sinusitis is classified as:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Acute: an infection lasting 7-30 days.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Subacute: the inflammation lasts 4-12 weeks.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Recurring: there are &gt;3 significant acute episodes in a year lasting ≥10 days with no intervening symptoms.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chronic: symptoms persist for &gt;90 days (these may be caused by irreversible changes in the mucosal lining of the sinuses), with or without acute exacerbations.</p>
</div></li>
</ul>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h2>
<p>This guidelines addresses the diagnosis and management of sinusitis.</p>
<h2 id="limitations">Limitations</h2>
<p>None</p>
<p><strong>Presenting symptoms and signs</strong></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>The maxillary and ethmoid sinuses are most commonly involved in sinusitis. The frontal sinuses are less often involved and the sphenoid sinuses are rarely affected.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Facial pain, sensation of pressure and tenderness over the affected sinus are present.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Purulent nasal discharge</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Fever, fatigue and headache</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Postnasal discharge</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Persistent coughing</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hyposmia or anosmia</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ear pressure or fullness</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Halitosis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Maxillary dental pain</p>
</div></li>
</ul>
<h3 id="sinusitis-in-children">Sinusitis in children</h3>
<p>There is some controversy as to whether this diagnosis can be made in young children who have very poorly developed sinuses - radiographic evidence of sinuses is only visible from about 9 years of age. Current consensus is that it can occur in children over the age of 1 year. Symptoms may vary a little from those of adults and can include <strong>irritability, lethargy, snoring, mouth breathing, feeding difficulty and hyponasal speech.</strong></p>
<p><strong>Examination findings</strong></p>
<p>The most helpful examination technique is simple palpation, as this is quick and easy to perform. Percussion and transillumination are also described although these are not reliable.</p>
<p>All but the sphenoidal sinuses can be palpated for tenderness:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p><strong>Frontal sinus</strong> - press upward beneath the medial side of the supraorbital ridge.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Maxillary sinus</strong> - press against the anterior wall, below the inferior orbital margin.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Ethmoidal sinus</strong> - press medially against the medial wall of the orbit.</p>
</div></li>
</ul>
<p>Other examination findings include</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Oedematous and hyperaemic nasal mucosa</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Purulent nasal secretions</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Purulent posterior pharyngeal secretions</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Periorbital oedema</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Air-fluid levels on transillumination of the sinuses</p>
</div></li>
</ul>
<h2 id="investigations">Investigations</h2>
<p>Diagnosis is clinical. Investigations are not necessary but may be done in the case of diagnostic uncertainty.</p>
<p><strong>X-ray findings</strong>: Thickening of the sinus mucosa and a fluid level are usually seen in x-ray films or magnetic resonance imaging. X-rays are not needed to make a diagnosis.</p>
<p>Diagnosis of acute bacterial sinusitis should be suspected if</p>
<ol type="1">
<li><div data-custom-style="List Paragraph">
<p>Presence of symptoms or signs for 10 days or more</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Worsening of symptoms or signs after an initial improvement.</p>
</div></li>
</ol>
<h2 id="management">Management </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Paracetamol (1 g TDS/QDS) or ibuprofen (200-600 mg TDS) for pain/fever.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Intranasal decongestant (oral is not recommended for sinusitis) for a maximum of a week.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nasal irrigation with warm saline solution.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Warm face packs may provide localised pain relief.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Adequate fluids and rest.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Antibiotics: for suspected bacterial sinusitis</p>
</div></li>
</ul>
<table>
<thead>
<tr class="header">
<th><strong>1<sup>st</sup> line antibiotics</strong></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Amoxicillin</td>
<td>1 g orally TDS or 80-90 mg/kg/day for 5 days</td>
</tr>
<tr class="even">
<td>Penicillin V</td>
<td><p>1 to 11 months, 62.5 mg QDS for 5 days</p>
<p>1 to 5 years, 125 mg QDS for 5 days</p>
<p>6 to 11 years, 250 mg QDS for 5 days</p>
<p>≥12 years, 500 mg QDS for 5 days</p></td>
</tr>
<tr class="odd">
<td>Doxycycline</td>
<td><p>PO 200 mg BD for 5-7 days</p>
<p>NB: contraindicated in pregnancy and children less than 8 years</p></td>
</tr>
<tr class="even">
<td>Erythromycin (recommended in pregnancy)</td>
<td><p>PO 400 mg QDS for 10-14 days (may increase to 4 g/day depending on severity) or</p>
<p>30-50 mg/kg/day; can give 60-100 mg/kg/day in severe infection</p></td>
</tr>
<tr class="odd">
<td>Azithromycin</td>
<td><p>PO 500 mg/day for 3 days or 2 g once</p>
<p>Paeds: 10 mg/kg/day for 3 days</p></td>
</tr>
<tr class="even">
<td><strong>2<sup>nd</sup> line antibiotics</strong></td>
<td></td>
</tr>
<tr class="odd">
<td>Co-amoxiclav</td>
<td>500 mg of amoxicillin TDS for 5 - 10 days or 40 mg/kg/day</td>
</tr>
<tr class="even">
<td>Ciprofloxacin</td>
<td>PO 500 mg BD or IV 400 mg BD for 10 days</td>
</tr>
</tbody>
</table>
<p>Admit patient if there is severe systemic infection, complications of sinusitis and immunocompromised patients.</p>
<p><strong><br />
</strong></p>
<p><strong>Complications are rare</strong>. They occur more commonly in children. They include orbital cellulitis, meningitis, brain abscess, osteomyelitis (known as Pott&#39;s puffy tumour when the frontal bone is affected) and cavernous sinus thrombosis. Acute sinusitis can become chronic.</p>
<p><strong>Refer for urgent ENT review if</strong>:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>there are unilateral symptoms (eg, mass, bloodstained discharge, crusting, non-tender facial pain, facial swelling or unilateral nasal polyps or unilateral nasal polyps).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>persistent infections (three or more attacks per year) or</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>persistent symptoms despite an adequate course of second-line antibiotics.</p>
</div></li>
</ul>
<p><strong>Prognosis</strong></p>
<p>Symptoms are likely to be relatively slow to resolve (2-3 weeks, regardless of whether antibiotics are taken or not) but over two-thirds of patients experience improvement or resolution of symptoms without antibiotic treatment.</p>
<h2 id="references">References</h2>
<p>Colledge, Nicki R., Brian R. Walker, Stuart Ralston, and Stanley Davidson. 2010. Davidson&#39;s principles and practice of medicine. Edinburgh: Churchill Livingstone/Elsevier.</p>
<p>Henderson R (2014). Sinusitis. Certified by The Information Standard. Retrieved from <a href="https://patient.info/doctor/sinusitis-pro"><span data-custom-style="Hyperlink">https://patient.info/doctor/sinusitis-pro</span></a> on 23/02/19.</p>
<p>Kliegman, Robert., et al. Nelson Textbook of Pediatrics. 20<sup>th</sup> Edition. Philadelphia, PA: Elsevier, 2016.</p>
<p>Sinusitis (acute): antimicrobial prescribing. NICE. Retrieved from <a href="https://www.nice.org.uk/guidance/ng79/documents/consultation-document"><span data-custom-style="Hyperlink">https://www.nice.org.uk/guidance/ng79/documents/consultation-document</span></a> on 23/02/19.</p>
<p>Standard Treatment Guidelines, 6th Edition, 2010. ISBN 978-9988-1-2538-7</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Fatoumata Sawaneh</th>
<th>Date: 27 February 2019</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Baderinwa Abatan</td>
<td>Date: 03 May 2019</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 May 2021</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
